Investor Presentaiton

Laurus Labs Limited Corporate Office 2nd Floor, Serene Chambers, Road No. 7 Banjara Hills, Hyderabad - 500034, Telangana, India T +91 40 6659 4333, 3980 4333, 2342 0500/501 F +91 40 6659 4320/3980 4320 8 LAURUS Labs AUR Knowledge. Innovation. Excellence October 29, 2020 To The Corporate Relations Department BSE Limited Phiroz Jeejeebhoy Towers, 25th Floor, Dalal Street Mumbai 400001 Code: 540222 To The Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East) Mumbai 400 051 Code: LAURUSLABS Dear Sirs, Sub: Investors/Analysts Presentation Please find enclosed the presentation to the Investors/Analysts on the Unaudited Financial Results of the Company for the Quarter and Half year ended September 30, 2020, for the Investors/Analysts call scheduled on October 30, 2020, which was already intimated on October 26, 2020. The presentation is also being uploaded on the website of the Company www.lauruslabs.com. Please take the information on record. Thanking you, Yours sincerely, For Laurus Labs Limited LABS Hyderabad) LIMITED V.V. Ravi Kumar Executive Director & * Chief Financial Officer Encl: As above Registered Office: Plot No:21, Jawaharlal Nehru Pharma City, Parawada, Visakhapatnam - 531021, Andhra Pradesh, India. CIN: L24239AP2005PLC047518 T +91 891 660 1222, 306 1222, F +91 891 660 1270, 306 1270, E [email protected] W lauruslabs.com LAURUS Generics LAURUS Generics LAURUS Synthesis LAURUS Ingredients Active Pharmaceutical Ingredients & Intermediates Finished Dosage Forms Contract Development & Manufacturing Services Specialty Ingredients for Nutraceutical & Allied Industry

View entire presentation